(Q33849118)

29 July 2017

title

Fenofibrate Reduces Age-related Hypercholesterolemia in Normal Rats on a Standard Diet (English)

1 reference

29 July 2017

0 references

Eunhui Seo

4

0 references

Eunhui Seo

object named as

Eunhui Seo

4

0 references

author name string

Ying Han

1

1 reference

29 July 2017

Mi-Hyang Do

2

1 reference

29 July 2017

Mi Sun Kim

3

1 reference

29 July 2017

Mi-Kyoung Park

5

1 reference

29 July 2017

Duk Kyu Kim

6

1 reference

29 July 2017

Hye-Jeong Lee

7

1 reference

29 July 2017

Su-Yeong Seo

8

1 reference

29 July 2017

publication date

30 April 2010

1 reference

Korean Journal of Physiology and Pharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

14

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

77-81

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

29 July 2017

copyright license

start time

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Hypercholesterolemia and 3-hydroxy-3-methylglutaryl coenzyme A reductase regulation in aged female rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

PPAR-alpha effects on the heart and other vascular tissues

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Fenofibrate in the treatment of dyslipidemia: a review of the data as they relate to the new suprabioavailable tablet formulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Peroxisome proliferator-activated receptor agonists.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Influence of age on the metabolism of plasma low density lipoproteins in healthy males

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Effects of fenofibrate on plasma and hepatic transaminase activities and hepatic transaminase gene expression in rats

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2869456

The influence of age on low density lipoprotein metabolism: effects of cholestyramine treatment in young and old healthy male subjects

29 October 2018

1 reference

12 December 2020

Fenofibrate improves age-related endothelial dysfunction in rat resistance arteries

1 reference

12 December 2020

Drug treatment of dyslipidemias: practical guidelines for the primary care physician

1 reference

12 December 2020

Efficacy and safety of micronised fenofibrate in a randomised double-blind study comparing four doses from 200 mg to 400 mg daily with placebo in patients with hypercholesterolemia

1 reference

12 December 2020

The hyperleptinemia and ObRb expression in hyperphagic obese rats

1 reference

12 December 2020

10.4196/KJPP.2010.14.2.77

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference